Search

everythinglearnresearchcommunity

for

Search:↓

A wearable device using electric stimulation can significantly improve hair growth.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Light microscopy is useful for diagnosing different hair disorders.

Hair in mammals likely evolved from glandular structures, not scales.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.